Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Corcept Therapeutics (CORT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,086,461
  • Shares Outstanding, K 114,830
  • Annual Sales, $ 159,200 K
  • Annual Income, $ 129,120 K
  • 36-Month Beta 1.88
  • Price/Sales 12.93
  • Price/Cash Flow 38.92
  • Price/Book 10.71

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.22 +16.40%
on 04/02/18
18.28 -3.12%
on 04/19/18
+0.26 (+1.49%)
since 03/20/18
3-Month
13.39 +32.26%
on 02/09/18
25.96 -31.78%
on 01/29/18
-6.27 (-26.15%)
since 01/19/18
52-Week
8.90 +98.99%
on 04/21/17
25.96 -31.78%
on 01/29/18
+7.72 (+77.28%)
since 04/20/17

Most Recent Stories

More News
Why Is Corcept Therapeutics (CORT) Up 5.3% Since Its Last Earnings Report?

Corcept Therapeutics (CORT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

CORT : 17.66 (-2.81%)
Stock Review for Biotech's Investors -- Concert Pharma, ContraVir Pharma, Corbus Pharma, and Corcept Therapeutics

WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on CNCE, CTRV, CRBP, and CORT which can be accessed for free by signing up to www.wallstequities.com/registration....

CORT : 17.66 (-2.81%)
CNCE : 19.08 (+0.16%)
CRBP : 6.68 (-1.04%)
CTRV : 0.27 (unch)
Corcept Plans Korlym Label Expansion, Pipeline in Progress

Corcept (CORT) is currently working on developing Korlym for additional indications. It also remains focused at the development of its pipeline progress.

CORT : 17.66 (-2.81%)
LGND : 168.30 (-0.18%)
ENTA : 87.74 (+1.69%)
REGN : 312.70 (-0.99%)
Wired News - Sangamo Gets CTA from UK Agency for Evaluating SB-FIX for Treatment of Hemophilia B

Stock Monitor: Corcept Therapeutics Post Earnings Reporting

SGMO : 19.15 (-0.26%)
CORT : 17.66 (-2.81%)
New Research: Key Drivers of Growth for Corcept Therapeutics, HubSpot, Tableau Software, Balchem, Steelcase, and Chimerix -- Factors of Influence, Major Initiatives and Sustained Production

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Corcept Therapeutics Incorporated...

CORT : 17.66 (-2.81%)
SCS : 13.85 (-1.42%)
DATA : 84.30 (-0.11%)
BCPC : 89.53 (+0.27%)
HUBS : 114.15 (-1.34%)
CMRX : 5.05 (+1.00%)
Corcept's (CORT) Earnings and Sales Meet Estimates in Q4

Corcept (CORT) reports in-line results for the fourth quarter of 2017 and also announces top-line interim phase II data for its pipeline candidate relacorilant.

CORT : 17.66 (-2.81%)
ENTA : 87.74 (+1.69%)
EXEL : 20.83 (-1.23%)
REGN : 312.70 (-0.99%)
Corcept Therapeutics Announces 2017 Financial Results and Positive Interim Results of Relacorilant Phase 2 Trial

Corcept Therapeutics Incorporated (NASDAQ:CORT), a company engaged in the discovery, development and commercialization of drugs to treat severe metabolic, oncologic and psychiatric disorders by modulating...

CORT : 17.66 (-2.81%)
Corcept Therapeutics Incorporated. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / February 22, 2018 / Corcept Therapeutics Incorporated. (NASDAQ: CORT) will be discussing their earnings results in their Q4 Earnings Call to be held on February 22, 2018 at...

CORT : 17.66 (-2.81%)
Corcept Therapeutics to Announce Fourth Quarter and Full-Year 2017 Financial Results, Provide Corporate Update, Host Conference Call

Corcept Therapeutics Incorporated (NASDAQ:CORT) today announced it will report its 2017 financial results and provide a corporate update on

CORT : 17.66 (-2.81%)
Wells Fargo and Aronic skid while Broadcom climbs

NEW YORK (AP) — Stocks that moved substantially or traded heavily Monday:

CORT : 17.66 (-2.81%)
BRCM : 54.67 (+0.31%)
BG : 73.85 (-2.44%)
QCOM : 51.67 (-1.71%)
XOM : 78.71 (-0.89%)
ARNC : 23.36 (-0.72%)
ADM : 45.30 (-1.07%)
CHD : 46.11 (-5.36%)
KEX : 85.75 (-0.41%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Corcept Therapeutics Incorporated is a pharmaceutical company. It is engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. The company focuses on disorders that are associated with a steroid hormone called cortisol....

See More

Key Turning Points

2nd Resistance Point 18.80
1st Resistance Point 18.49
Last Price 17.69
1st Support Level 17.65
2nd Support Level 17.12

See More

52-Week High 25.96
Fibonacci 61.8% 19.44
Last Price 17.69
Fibonacci 50% 17.43
Fibonacci 38.2% 15.42
52-Week Low 8.90

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar